Sapreme Technologies
Series ASapreme Technologies raised €15M in a Series A round in Oct 2021. The company is based in Utrecht, Netherlands. Investors in the round: Aglaia Oncology Funds. Data as of Nov 2026.
Amount raised
€15M
€15,000,000
Native amount
15,000,000 EUR
Stage
Series A
series a
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €15M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyRelated news
- Dutch biotech company Sapreme raises €15M to develop therapies to treat cancer; know more heresiliconcanals.com · 2021-10